Altshuler Shaham’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.04K Sell
29
-4
-12% -$560 ﹤0.01% 318
2025
Q4
$4.05K Buy
+33
New +$4.01K ﹤0.01% 321
2023
Q2
Sell
-1,414
Closed -$117K 346
2023
Q1
$117K Sell
1,414
-442
-24% -$36.6K ﹤0.01% 121
2022
Q4
$159K Buy
1,856
+121
+7% +$9.58K 0.01% 105
2022
Q3
$109K Sell
1,735
-171
-9% -$10.8K ﹤0.01% 156
2022
Q2
$118K Buy
1,906
+251
+15% +$15.5K ﹤0.01% 175
2022
Q1
$99K Buy
1,655
+969
+141% +$61.9K ﹤0.01% 266
2021
Q4
$50K Sell
686
-1,901
-73% -$131K ﹤0.01% 422
2021
Q3
$182K Buy
2,587
+1,973
+321% +$139K ﹤0.01% 267
2021
Q2
$42K Sell
614
-524
-46% -$35K ﹤0.01% 471
2021
Q1
$74K Buy
+1,138
New +$73.4K ﹤0.01% 263
2020
Q3
Sell
-1,239
Closed -$96K 401
2020
Q2
$96K Buy
1,239
+1,226
+9,431% +$94K ﹤0.01% 170
2020
Q1
$1K Hold
13
﹤0.01% 403
2019
Q4
$1K Buy
13
+9
+225% +$586 ﹤0.01% 446
2019
Q3
$0 Buy
+4
New +$261 ﹤0.01% 471

Other funds holding GILD

Altshuler Shaham's GILD Position: Q1 2026 in Review

Altshuler Shaham reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $560 and leaving 29 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Altshuler Shaham first reported a position in GILD in Q3 2019 and has held it in 15 quarters since. The position peaked at $182K in Q3 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Altshuler Shaham held 29 shares of Gilead Sciences worth $4.04K as of Q1 2026.
  • Altshuler Shaham sold 4 Gilead Sciences shares in Q1 2026, an estimated $560.
  • Gilead Sciences made up ﹤0.01% of Altshuler Shaham's portfolio in Q1 2026, its #318 holding.
  • Altshuler Shaham first reported a position in Gilead Sciences in Q3 2019 and has held it in 15 quarters since.
  • Altshuler Shaham's Gilead Sciences position peaked at $182K in Q3 2021.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Altshuler Shaham's 13F filing for Q1 2026, filed 18 May 2026.